Literature DB >> 21479666

A pediatric case of cardiomyopathy induced by inappropriate sinus tachycardia: efficacy of ivabradine.

Emanuele Romeo1, Nicola Grimaldi, Berardo Sarubbi, Michele D'Alto, Giuseppe Santarpia, Giancarlo Scognamiglio, Maria Giovanna Russo, Raffaele Calabrò.   

Abstract

We report the case of a 16-year-old boy with cardiomyopathy induced by inappropriate sinus tachycardia (IST). The patient was resistant to treatment with conventional rate-decreasing medications. Therapy with the selective sinus node I(f) current inhibitor ivabradine was started. After 3 months of ivabradine therapy, an improvement in ejection fraction and a successful decrease in heart rate were observed. No side effects occurred. We suggest that ivabradine, currently used to treat stable angina, could be considered as a second-line treatment in patients with symptomatic and refractory IST.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21479666     DOI： 10.1007/s00246-011-9964-1

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN： 0172-0643            Impact factor:   1.655


  11 in total

Review 1.  How to manage patients with inappropriate sinus tachycardia.

Authors:  Win K Shen
Journal:  Heart Rhythm       Date:  2005-09       Impact factor: 6.343

Review 2.  Tachycardia-induced cardiomyopathy: a review of literature.

Authors:  Atul Khasnis; Krit Jongnarangsin; George Abela; Srikar Veerareddy; Vivek Reddy; Ranjan Thakur
Journal:  Pacing Clin Electrophysiol       Date:  2005-07       Impact factor: 1.976

Review 3.  Tachycardia-induced cardiomyopathy: a review of animal models and clinical studies.

Authors:  J S Shinbane; M A Wood; D N Jensen; K A Ellenbogen; A P Fitzpatrick; M M Scheinman
Journal:  J Am Coll Cardiol       Date:  1997-03-15       Impact factor: 24.094

4.  Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study.

Authors:  Karl Swedberg; Michel Komajda; Michael Böhm; Jeffrey S Borer; Ian Ford; Ariane Dubost-Brama; Guy Lerebours; Luigi Tavazzi
Journal:  Lancet       Date:  2010-09-11       Impact factor: 79.321

Review 5.  Inappropriate sinus tachycardia, postural orthostatic tachycardia syndrome, and overlapping syndromes.

Authors:  Peter A Brady; Phillip A Low; Win K Shen
Journal:  Pacing Clin Electrophysiol       Date:  2005-10       Impact factor: 1.976

6.  Three-dimensional nonfluoroscopic mapping and ablation of inappropriate sinus tachycardia. Procedural strategies and long-term outcome.

Authors:  Nassir F Marrouche; Salwa Beheiry; Gery Tomassoni; Christopher Cole; Dianna Bash; Thomas Dresing; Walid Saliba; Ahmad Abdul-Karim; Patrick Tchou; Robert Schweikert; Fabio Leonelli; Andrea Natale
Journal:  J Am Coll Cardiol       Date:  2002-03-20       Impact factor: 24.094

7.  Treatment of inappropriate sinus tachycardia with ivabradine in a patient with postural orthostatic tachycardia syndrome and a dual chamber pacemaker.

Authors:  Sitara Khan; Shoaib Hamid; Christopher Rinaldi
Journal:  Pacing Clin Electrophysiol       Date:  2009-01       Impact factor: 1.976

8.  A case of cardiomyopathy induced by inappropriate sinus tachycardia and cured by ivabradine.

Authors:  Pierre-Francois Winum; Guillaume Cayla; Madeleine Rubini; Lionel Beck; Patrick Messner-Pellenc
Journal:  Pacing Clin Electrophysiol       Date:  2009-07       Impact factor: 1.976

Review 9.  Sinus tachyarrhythmias and the specific bradycardic agents: a marriage made in heaven?

Authors:  Shamil Yusuf; A John Camm
Journal:  J Cardiovasc Pharmacol Ther       Date:  2003-06       Impact factor: 2.457

10.  Ivabradine as an alternative therapeutic trial in the therapy of inappropriate sinus tachycardia: a case report.

Authors:  Volker Schulze; Stefan Steiner; Marcus Hennersdorf; Bodo-Eckehard Strauer
Journal:  Cardiology       Date:  2007-12-04       Impact factor: 1.869
View more
  5 in total

Review 1.  Current understanding of the pathophysiological mechanisms responsible for inappropriate sinus tachycardia: role of the If "funny" current.

Authors:  Mirko Baruscotti; Elisabetta Bianco; Annalisa Bucchi; Dario DiFrancesco
Journal:  J Interv Card Electrophysiol       Date:  2016-01-18       Impact factor: 1.900

2.  2015 heart rhythm society expert consensus statement on the diagnosis and treatment of postural tachycardia syndrome, inappropriate sinus tachycardia, and vasovagal syncope.

Authors:  Robert S Sheldon; Blair P Grubb; Brian Olshansky; Win-Kuang Shen; Hugh Calkins; Michele Brignole; Satish R Raj; Andrew D Krahn; Carlos A Morillo; Julian M Stewart; Richard Sutton; Paola Sandroni; Karen J Friday; Denise Tessariol Hachul; Mitchell I Cohen; Dennis H Lau; Kenneth A Mayuga; Jeffrey P Moak; Roopinder K Sandhu; Khalil Kanjwal
Journal:  Heart Rhythm       Date:  2015-05-14       Impact factor: 6.343

Review 3.  Sinus Tachycardia: a Multidisciplinary Expert Focused Review.

Authors:  Kenneth A Mayuga; Artur Fedorowski; Fabrizio Ricci; Rakesh Gopinathannair; Jonathan Walter Dukes; Christopher Gibbons; Peter Hanna; Dan Sorajja; Mina Chung; David Benditt; Robert Sheldon; Mirna B Ayache; Hiba AbouAssi; Kalyanam Shivkumar; Blair P Grubb; Mohamed H Hamdan; Stavros Stavrakis; Tamanna Singh; Jeffrey J Goldberger; James A S Muldowney; Mark Belham; David C Kem; Cem Akin; Barbara K Bruce; Nicole E Zahka; Qi Fu; Erik H Van Iterson; Satish R Raj; Fetnat Fouad-Tarazi; David S Goldstein; Julian Stewart; Brian Olshansky
Journal:  Circ Arrhythm Electrophysiol       Date:  2022-09-08

Review 4.  Clinical presentation of inappropriate sinus tachycardia and differential diagnosis.

Authors:  Michael Peyrol; Samuel Lévy
Journal:  J Interv Card Electrophysiol       Date:  2015-09-02       Impact factor: 1.900

5.  Baseline intrinsic heart rate and response to ivabradine treatment in patients with inappropriate sinus tachycardia.

Authors:  Krzysztof Kaczmarek; Thomas Klingenheben; Izabela Poddebska; Irmina Urbanek; Jerzy K Wranicz; Iwona Cygankiewicz; Pawel Ptaszyński
Journal:  Ann Noninvasive Electrocardiol       Date:  2019-10-08       Impact factor: 1.468
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.